Medizinische Universität Graz - Research portal

• Go directly to the nagivation.
• Go directly to the content.

• Print view.
• German.
• Contact.
• Data entry.
• Start.
• Open Access.

Effect of the novel lipid-lowering therapy niacin plus laropiprant (Tredaptive®) on platelet function: Benefit or hazard?

Project Leader:

Heinemann Akos

Duration:

01.10.2011-30.09.2015

Type of Research

basic research

Staff

Heinemann, Akos, Project Leader

MUG Research Units

Division of Pharmacology

Funded by

Österreichische Nationalbank (Jubiläumsfonds), Otto Wagner Platz 3, A-1090 Wien, Austria